Paradiem LLC Has $6.76 Million Stock Position in Cabot Corporation $CBT

Key Points

• Paradiem LLC reduced its stake in Cabot Corporation by 45.4%, owning 90,067 shares worth approximately $6.76 million, making it the 23rd largest holding in its portfolio.
• Cabot recently reported $1.90 earnings per share (EPS), beating expectations, and posted revenues of $923 million, which fell short of analyst estimates.
• The company announced a quarterly dividend of $0.45 per share, representing an annual yield of 2.4% and a dividend payout ratio of 23.53%.

Paradiem LLC trimmed its position in shares of Cabot Corporation (NYSE:CBT - Free Report) by 45.4% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 90,067 shares of the specialty chemicals company's stock after selling 74,988 shares during the quarter. Cabot accounts for 1.7% of Paradiem LLC's investment portfolio, making the stock its 23rd largest holding. Paradiem LLC owned 0.17% of Cabot worth $6,755,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. LSV Asset Management grew its holdings in shares of Cabot by 318.0% during the first quarter. LSV Asset Management now owns 571,034 shares of the specialty chemicals company's stock valued at $47,476,000 after buying an additional 434,434 shares during the last quarter. American Century Companies Inc. lifted its position in Cabot by 13.2% in the 1st quarter. American Century Companies Inc. now owns 1,498,268 shares of the specialty chemicals company's stock valued at $124,566,000 after acquiring an additional 174,921 shares in the last quarter. AQR Capital Management LLC boosted its stake in Cabot by 79.5% during the 1st quarter. AQR Capital Management LLC now owns 389,244 shares of the specialty chemicals company's stock valued at $31,626,000 after purchasing an additional 172,410 shares during the last quarter. Nuveen LLC bought a new stake in Cabot during the 1st quarter worth approximately $12,365,000. Finally, GAMMA Investing LLC increased its holdings in Cabot by 10,385.0% during the 1st quarter. GAMMA Investing LLC now owns 141,338 shares of the specialty chemicals company's stock worth $11,751,000 after purchasing an additional 139,990 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company's stock.

Cabot Price Performance

Cabot stock opened at $76.15 on Tuesday. Cabot Corporation has a 52 week low of $70.40 and a 52 week high of $117.46. The company's 50 day moving average price is $78.31 and its two-hundred day moving average price is $77.76. The stock has a market cap of $4.05 billion, a P/E ratio of 9.95 and a beta of 0.90. The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 0.66.

Cabot (NYSE:CBT - Get Free Report) last released its earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.80 by $0.10. The company had revenue of $923.00 million during the quarter, compared to analyst estimates of $957.29 million. Cabot had a return on equity of 25.68% and a net margin of 11.14%. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. On average, equities analysts predict that Cabot Corporation will post 7.57 earnings per share for the current year.

Cabot Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 11th. Investors of record on Friday, August 29th were issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date was Friday, August 29th. Cabot's dividend payout ratio (DPR) is 23.53%.

Insider Transactions at Cabot

In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of Cabot stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $79.28, for a total value of $9,072,486.08. Following the sale, the chief executive officer owned 361,518 shares of the company's stock, valued at approximately $28,661,147.04. The trade was a 24.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 3.03% of the company's stock.

Wall Street Analyst Weigh In

Separately, UBS Group set a $82.00 target price on Cabot and gave the company a "neutral" rating in a report on Tuesday, August 5th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Cabot currently has a consensus rating of "Hold" and an average price target of $92.33.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.